Stay updated on Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial
Sign up to get notified when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.

Latest updates to the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant content removal, particularly regarding the details of a clinical study on risankizumab for hidradenitis suppurativa, including objectives, criteria, and study design. The revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference9%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe webpage now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for the Help Desk.SummaryDifference1%
Stay in the know with updates to Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab vs Placebo in Hidradenitis Suppurativa Clinical Trial page.